InvestSMART

Microba Life Sciences Limited (ASX: MAP) - Announcements

Current share price for MAP : $0.048 0.001 (2.04%)+

ASX company news and announcements for Microba Life Sciences Limited (MAP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Microba Life Sciences Limited (MAP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Microba Life Sciences Limited (MAP), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Microba Life Sciences Limited (MAP)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$34 Proposed issue of securities - MAP 12 Jun 2026 9:46AM $0.063 $0.048 fallen by 23.81%
$34 Proposed issue of securities - MAP 12 Jun 2026 9:46AM $0.063 $0.048 fallen by 23.81%
$34 Investor presentation - path to cashflow breakeven 12 Jun 2026 9:46AM $0.063 $0.048 fallen by 23.81%
$34 $5M secured to deliver cashflow breakeven and testing growth 12 Jun 2026 9:45AM $0.063 $0.048 fallen by 23.81%
$34 Extension of Voluntary Suspension 11 Jun 2026 8:45AM $0.063 $0.048 fallen by 23.81%
$34 Suspension from Quotation 5 Jun 2026 9:39AM $0.063 $0.048 fallen by 23.81%
$34 Trading Halt 3 Jun 2026 10:00AM $0.063 $0.048 fallen by 23.81%
$34 Pause in Trading 3 Jun 2026 9:49AM $0.063 $0.048 fallen by 23.81%
$34 Notification of cessation of securities - MAP 30 Apr 2026 5:52PM $0.070 $0.048 fallen by 31.43%
$34 Q3 FY26 Quarterly Investor Presentation & Webinar 30 Apr 2026 9:17AM $0.070 $0.048 fallen by 31.43%
$34 Q3 FY26 Quarterly Activities Report & Appendix 4C 30 Apr 2026 9:12AM $0.070 $0.048 fallen by 31.43%
$34 Details of Q3 FY26 Quarterly Report, Appendix 4C & Webinar 28 Apr 2026 2:26PM $0.070 $0.048 fallen by 31.43%
$34 Appendix 4D & FY26 Interim Report 26 Feb 2026 9:05AM $0.085 $0.048 fallen by 43.53%
$34 Q2 FY26 Quarterly Investor Presentation & Webinar 29 Jan 2026 9:23AM $0.085 $0.048 fallen by 43.53%
$34 Q2 FY26 Quarterly Activities Report & Appendix 4C 29 Jan 2026 9:21AM $0.085 $0.048 fallen by 43.53%
$34 Details of Q2 FY26 Quarterly Report, Appendix 4C & Webinar 22 Jan 2026 9:19AM $0.091 $0.048 fallen by 47.25%
$34 Microba receives $3 million R&D Tax Incentive Refund 3 Dec 2025 8:50AM $0.073 $0.048 fallen by 34.25%
$34 Release of Restricted Securities 21 Nov 2025 5:14PM $0.072 $0.048 fallen by 33.33%
$34 Initial Director's Interest Notice - Stephane Chatonsky 20 Nov 2025 5:33PM $0.073 $0.048 fallen by 34.25%
$34 Final Director's Interest Notice - Richard Bund 20 Nov 2025 5:33PM $0.073 $0.048 fallen by 34.25%
$34 Final Director's Interest Notice - Hyungtae Kim 20 Nov 2025 5:32PM $0.073 $0.048 fallen by 34.25%
$34 Results of Annual General Meeting 19 Nov 2025 5:01PM $0.072 $0.048 fallen by 33.33%
$34 Change in substantial holding 12 Nov 2025 4:12PM $0.080 $0.048 fallen by 40%
$34 Board Renewal 12 Nov 2025 9:00AM $0.080 $0.048 fallen by 40%
$34 Becoming a substantial holder 31 Oct 2025 4:12PM $0.079 $0.048 fallen by 39.24%

26 - 50 of 693 results

Page 2 of 28

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.